LTRN Q1 2020 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena

LTRNLantern Pharma Inc.

$30M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$477,276

Net Income

-$477,276

EPS (Diluted)

$-0.08

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$703,048

Free Cash Flow

-$703,050

Stock-Based Comp.

$18,460

Balance Sheet

Total Assets

$1M

Total Liabilities

$501,526

Stockholders' Equity

$536,468

Cash & Equivalents

$634,247

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$477,276	-$453,973	-5.1%
Net Income	-$477,276	-$453,973	-5.1%